Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

Presentation TCT 2025

Bioprosthetic Valve Fracture: Benefits and Risks

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Key Takeaways

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Clinical Insights from Navitor

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

Presenter: Santiago Garcia

October 26, 2025

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

Presentation TCT 2025

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Presenter: Santiago Garcia

October 25, 2025

News Conference News NY Valves 2025

Promising Early Data With Navitor TAVI Valves

Yael L. Maxwell

July 02, 2025

News Conference News NY Valves 2025

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Yael L. Maxwell

June 30, 2025

Presentation NY Valves 2025

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Presenter: Santiago Garcia

June 27, 2025

Presentation NY Valves 2025

A Novel Robotic TMVR System (Capstan): First in Human Experience

Presenter: Santiago Garcia

June 27, 2025

Presentation NY Valves 2025

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

Presenter: Santiago Garcia

June 25, 2025

Presentation Miami Valves 2025

Novel TMVR Devices: CAPSTAN Medical

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Heterotopic Cross-Caval Tricuspid Valve Replacement- New Innovations

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Investigational Transeptal TMVR: SAPIEN M3

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Dedicated TAVR Devices for Chronic Aortic Regurgitation

Presenter: Santiago Garcia

January 30, 2025

Presentation TCT 2024

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Presenter: Santiago Garcia

October 30, 2024

Presentation TCT 2024

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Presenter: Santiago Garcia

October 28, 2024

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Todd Neale

August 31, 2024

Advertisement

Bioprosthetic Valve Fracture: Benefits and Risks

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Key Takeaways

Clinical Insights from Navitor

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

TTVR Remains Safe, Effective in Presence of CIED Leads

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Promising Early Data With Navitor TAVI Valves

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

A Novel Robotic TMVR System (Capstan): First in Human Experience

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

Novel TMVR Devices: CAPSTAN Medical

Heterotopic Cross-Caval Tricuspid Valve Replacement- New Innovations

Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status

Investigational Transeptal TMVR: SAPIEN M3

Dedicated TAVR Devices for Chronic Aortic Regurgitation

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content